One Lab, One Discovery: The Continuous Ripple Effect
POSTED: Tuesday, October 26, 2021
CATEGORY: Foundation News
Nearly six decades after cisplatin’s founding, the anti-cancer drug’s legacy resonates across the MSU landscape. Through the MSU Foundation, some $325 million in cisplatin and carboplatin royalties earned from 1979-2004 have pushed MSU investigators to pursue daring work, fueled enterprising interdisciplinary explorations and propelled countless entrepreneurial adventures.
“Cisplatin wasn’t just a home run,” current MSU Foundation Executive Director David Washburn said. “It was a grand slam.”
Read more at https://alumni.msu.edu/stay-informed/alumni-stories/one-lab-one-discove…